Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
European Journal of Epidemiology|September 17, 2003
Immune response to a diphtheria and tetanus toxoid administration in a three-dose diphtheria tetanus whole-cell pertussis/enhanced inactivated poliovirus vaccination schedule: a 7-year follow upT A Swartz, P Saliou, E Catznelson, et al.Beneficial Microbes|January 4, 2021
Heat inactivation partially preserved barrier and immunomodulatory effects of Lactobacillus gasseri LA806 in an in vitro model of bovine mastitisF Blanchet, L Rault, V Peton, et al.Biologicals : Journal of the International Association of Biological Standardization|September 1, 1996
Analysis of the antibody response in humans with a new inactivated hepatitis A vaccineE Vidor, C Xueref, C Blondeau, et al.Vaccine|December 15, 2000
Immunogenicity of a hexavalent combination vaccine in rhesus monkeysM J Caulfield, J G Smith, S Wang, et al.Sante (Montrouge, France)|January 1, 1996
[Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine]J P Moulia-Pelat, A Spiegel, J L Excler, et al.Journal of Immunological Methods|February 18, 1999
Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipientsM Raux, L Finkielsztejn, D Salmon-Céron, et al.Vaccine|January 1, 1992
Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccineP Coursaget, L Bringer, G Sarr, et al.AIDS Research and Human Retroviruses|October 9, 1999
Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjectsM Raux, L Finkielsztejn, D Salmon-Céron, et al.AIDS Research and Human Retroviruses|April 25, 2000
IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjectsM Raux, L Finkielsztejn, D Salmon-Céron, et al.The Pediatric Infectious Disease Journal|May 12, 1998
Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infantsR Lagos, K Kotloff, A Hoffenbach, et al.Pageof 8